Neither from words, nor from visions: understanding p-medicine from innovative treatments
DOI :
https://doi.org/10.20416/lsrsps.v4i2.793Mots-clés :
personalized medicine, precision medicineRésumé
Despite its vagueness Personalized, Precision, P4, P5, individualized, stratified medicine—or p-medicine in short—has become an increasingly popular term in biomedical literature. Philosophers have attempted to analyze what these various terms involve and have discussed consequences for medical practices. In this article, I argue that an important question remains unaddressed: what has made this project of p-medicine convincing to so many? My argument is that without real achievements, it would never have been. I also make the case that these achievements stem from the domain of monoclonal antibodies (mab), a new type of drug that justifies talks of personalized, precise, stratified, etc., medicine. In conclusion, while it may be possible to label any projection in the future of medicine as ‘p-medicine’, it is impossible to overlook mab-medicine as the spearhead.
Téléchargements
Publiée
Numéro
Rubrique
Licence
Ce travail est disponible sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
Les auteurs conservent le droit d'auteur et accordent à la revue le droit de première publication, l'ouvrage étant alors disponible simultanément, sous la licence Licence d’attribution Creative Commons permettant à d'autres de partager l'ouvrage tout en en reconnaissant la paternité et la publication initiale dans cette revue.
